Genextra S.p.A. 4

4 · INTERCEPT PHARMACEUTICALS INC · Filed Apr 9, 2018

Insider Transaction Report

Form 4
Period: 2018-04-09
Transactions
  • Purchase

    Common stock, par value $0.001 per share

    2018-04-09$64.00/sh+390,625$25,000,0006,845,578 total
Footnotes (1)
  • [F1]Represents shares of common stock purchased by Genextra S.p.A. in a private offering that was completed on April 9, 2018.

Documents

1 file
  • 4
    form4.xmlPrimary